Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Labopin

Showing results (31-40 of 121) with videos related to

Pageof 13
Sort By:
Bone Marrow Transplantation|September 20, 2016
Safety and efficacy of thiotepa-based conditioning for allogeneic transplantation in AML: a survey from the ALWP of the EBMTS Eder, M Labopin, J Finke, et al.
Blood|January 15, 1995
Autologous bone marrow transplantation for first remission acute myeloblastic leukemia in patients older than 50 years: a retrospective analysis of the European Bone Marrow Transplant GroupJ Y Cahn, M Labopin, F Mandelli, et al.
Leukemia|October 1, 1991
Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT)N C Gorin, M Labopin, G Meloni, et al.
Bone Marrow Transplantation|April 17, 2012
Impact of cytogenetics risk on outcome after reduced intensity conditioning allo-SCT from an HLA-identical sibling for patients with AML in first CR: a report from the acute leukemia working party of EBMTP Chevallier, M Labopin, N Milpied, et al.
Bone Marrow Transplantation|October 21, 2014
Impact of rabbit ATG-containing myeloablative conditioning regimens on the outcome of patients undergoing unrelated single-unit cord blood transplantation for hematological malignanciesL Pascal, M Mohty, A Ruggeri, et al.
Leukemia|August 22, 2015
Is there a stronger graft-versus-leukemia effect using HLA-haploidentical donors compared with HLA-identical siblings?O Ringdén, M Labopin, F Ciceri, et al.
British Journal of Haematology|October 29, 2000
Feasibility and recent improvement of autologous stem cell transplantation for acute myelocytic leukaemia in patients over 60 years of age: importance of the source of stem cellsN C Gorin, M Labopin, P Pichard, et al.
Leukemia|July 30, 2003
Risk assessment in adult acute lymphoblastic leukaemia before early haemopoietic stem cell transplantation with a geno-identical donor: an easy clinical prognostic score to identify patients who benefit most from allogeneic haemopoietic stem cell transplantationN-C Gorin, M Labopin, E Polge, et al.
Leukemia|June 11, 2014
Prediction of non-relapse mortality in recipients of reduced intensity conditioning allogeneic stem cell transplantation with AML in first complete remissionJ Versluis, M Labopin, D Niederwieser, et al.
Blood|December 1, 1994
One hundred twenty-five adult patients with primary acute leukemia autografted with marrow purged by mafosfamide: a 10-year single institution experienceJ P Laporte, L Douay, M Lopez, et al.
Pageof 13

Showing results (31-40 of 121) with videos related to

Sort By:
Pageof 13
Bone Marrow Transplantation|September 20, 2016
Safety and efficacy of thiotepa-based conditioning for allogeneic transplantation in AML: a survey from the ALWP of the EBMTS Eder, M Labopin, J Finke, et al.
Blood|January 15, 1995
Autologous bone marrow transplantation for first remission acute myeloblastic leukemia in patients older than 50 years: a retrospective analysis of the European Bone Marrow Transplant GroupJ Y Cahn, M Labopin, F Mandelli, et al.
Leukemia|October 1, 1991
Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT)N C Gorin, M Labopin, G Meloni, et al.
Bone Marrow Transplantation|April 17, 2012
Impact of cytogenetics risk on outcome after reduced intensity conditioning allo-SCT from an HLA-identical sibling for patients with AML in first CR: a report from the acute leukemia working party of EBMTP Chevallier, M Labopin, N Milpied, et al.
Bone Marrow Transplantation|October 21, 2014
Impact of rabbit ATG-containing myeloablative conditioning regimens on the outcome of patients undergoing unrelated single-unit cord blood transplantation for hematological malignanciesL Pascal, M Mohty, A Ruggeri, et al.
Leukemia|August 22, 2015
Is there a stronger graft-versus-leukemia effect using HLA-haploidentical donors compared with HLA-identical siblings?O Ringdén, M Labopin, F Ciceri, et al.
British Journal of Haematology|October 29, 2000
Feasibility and recent improvement of autologous stem cell transplantation for acute myelocytic leukaemia in patients over 60 years of age: importance of the source of stem cellsN C Gorin, M Labopin, P Pichard, et al.
Leukemia|July 30, 2003
Risk assessment in adult acute lymphoblastic leukaemia before early haemopoietic stem cell transplantation with a geno-identical donor: an easy clinical prognostic score to identify patients who benefit most from allogeneic haemopoietic stem cell transplantationN-C Gorin, M Labopin, E Polge, et al.
Leukemia|June 11, 2014
Prediction of non-relapse mortality in recipients of reduced intensity conditioning allogeneic stem cell transplantation with AML in first complete remissionJ Versluis, M Labopin, D Niederwieser, et al.
Blood|December 1, 1994
One hundred twenty-five adult patients with primary acute leukemia autografted with marrow purged by mafosfamide: a 10-year single institution experienceJ P Laporte, L Douay, M Lopez, et al.
Pageof 13